OPSUMIT.COM: Keyword Density Checker

Total words: 2235 | 2-word phrases: 566 | 3-word phrases: 636 | 4-word phrases: 666

PAGE INFO

Title	Try to keep the title under 60 characters (70 characters) OPSUMIT® (macitentan) Pulmonary Arterial Hypertension (PAH) Treatment
Description	Try to keep the meta description between 50 - 160 characters (140 characters) Learn about OPSUMIT, a treatment option for PAH (WHO Group 1). See Important Safety Info, including Important Warning, Full PI, & Med Guide.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	No H1 tag on the page (0 characters)

#	Keyword	Frequency	Density
1	pulmonary arterial hypertension	8	1.26%
2	important safety information	6	0.94%
3	package insert south	5	0.79%
4	of pulmonary hypertension	5	0.79%
5	pharmaceuticals us inc	5	0.79%
6	francisco ca actelion	5	0.79%
7	pah finding support	4	0.63%
8	for patients with	4	0.63%
9	opsumit® package insert	4	0.63%
10	actelion pharmaceuticals us	4	0.63%
11	insert south san	4	0.63%
12	ca actelion pharmaceuticals	4	0.63%
13	opsumit® can help	4	0.63%
14	j am coll	3	0.47%
15	treating pah finding	3	0.47%
16	look pah symptoms	3	0.47%
17	symptoms and diagnosis	3	0.47%
18	pah symptoms and	3	0.47%
19	pah a closer	3	0.47%
20	understanding pah pah	3	0.47%
21	opsumit® taking opsumit®	3	0.47%
22	on opsumit® taking	3	0.47%
23	finding support janssen	3	0.47%
24	guidelines for the	3	0.47%
25	carepath pah companion	3	0.47%
26	pah companion withme	3	0.47%
27	san francisco ca	3	0.47%
28	caring for someone	3	0.47%
29	for someone with	3	0.47%
30	someone with pah	3	0.47%

#	Keyword	Frequency	Density
1	opsumit® package insert south	4	0.60%
2	francisco ca actelion pharmaceuticals	4	0.60%
3	ca actelion pharmaceuticals us	4	0.60%
4	actelion pharmaceuticals us inc	4	0.60%
5	package insert south san	4	0.60%
6	look pah symptoms and	3	0.45%
7	can help benefits of	3	0.45%
8	simonneau g advances in	3	0.45%
9	started on opsumit® taking	3	0.45%
10	on opsumit® taking opsumit®	3	0.45%
11	g advances in therapeutic	3	0.45%
12	interventions for patients with	3	0.45%
13	understanding pah pah a	3	0.45%
14	pah pah a closer	3	0.45%
15	someone with pah additional	3	0.45%
16	pah symptoms and diagnosis	3	0.45%
17	j am coll cardiol	3	0.45%
18	jaïs x sitbon o	3	0.45%
19	treating pah finding support	3	0.45%
20	pah finding support janssen	3	0.45%
21	san francisco ca actelion	3	0.45%
22	carepath pah companion withme	3	0.45%
23	caring for someone with	3	0.45%
24	for someone with pah	3	0.45%
25	opsumit® can help benefits	3	0.45%
26	opsumit® important safety information	3	0.45%
27	d jaïs x sitbon	3	0.45%
28	and treatment of pulmonary	3	0.45%
29	in pulmonary arterial hypertension	3	0.45%
30	vachiery jl et al	3	0.45%
31	m vachiery jl et	3	0.45%
32	humbert m lau em	3	0.45%
33	humbert m vachiery jl	3	0.45%
34	n humbert m vachiery	3	0.45%
35	guidelines for the diagnosis	3	0.45%
36	eur respir j 2015464903975	3	0.45%
37	montani d jaïs x	3	0.45%
38	treatment of pulmonary hypertension	2	0.30%
39	south san francisco ca	2	0.30%
40	escers guidelines for the	2	0.30%